Christian B. Voigtlander Sells 1,430 Shares of ICU Medical, Inc. (NASDAQ:ICUI) Stock

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 1,430 shares of ICU Medical stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Christian B. Voigtlander also recently made the following trade(s):

• On Monday, November 25th, Christian B. Voigtlander sold 1,962 shares of ICU Medical stock. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96.

ICU Medical Stock Performance

Shares of NASDAQ ICUI traded up $2.00 during midday trading on Wednesday, reaching $159.75. The company had a trading volume of 245,094 shares, compared to its average volume of 274,609. The business’s 50-day simple moving average is $175.61 and its 200 day simple moving average is $146.51. The stock has a market cap of $3.91 billion, a P/E ratio of -34.62 and a beta of 0.66. ICU Medical, Inc. has a 1 year low of $83.26 and a 1 year high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the business. Franklin Resources Inc. grew its position in ICU Medical by 99.3% during the third quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier’s stock valued at $2,111,000 after buying an additional 5,834 shares during the period. Coldstream Capital Management Inc. acquired a new stake in shares of ICU Medical in the third quarter valued at about $227,000. Geode Capital Management LLC grew its position in shares of ICU Medical by 9.6% in the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after purchasing an additional 48,106 shares during the period. Barclays PLC grew its position in shares of ICU Medical by 15.6% in the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock valued at $10,790,000 after purchasing an additional 8,010 shares during the period. Finally, XTX Topco Ltd acquired a new stake in shares of ICU Medical in the third quarter valued at about $342,000. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. KeyCorp lifted their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Raymond James boosted their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Jefferies Financial Group began coverage on shares of ICU Medical in a research note on Monday, October 14th. They issued a “hold” rating and a $183.00 price target on the stock. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $173.00.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.